Top Medical News
16 hours ago
A significant association exists between tumour volume-related parameters and radical prostatectomy, suggests a study. However, these parameters do not add important discriminatory value to standard clinicopathological variable for radical prostatectomy prediction or provide benefit across a range of clinically relevant decision thresholds.
Yesterday
The diagnostic yield of prostate cancer per biopsy core has increased with the introduction of prebiopsy multiparametric magnetic resonance imaging (PMMRI), a study has shown.
3 days ago
The minimally invasive water vapour thermal therapy represents a viable approach for thermal ablative reduction of benign prostate hyperplasia (BPH), providing urinary symptom relief and quality of life improvement that are sustained over 4 years, a study has shown.
Audrey Abella, 07 Feb 2019
The selective serotonin reuptake inhibitor paroxetine fared better than fluoxetine and escitalopram in managing premature ejaculation (PE), demonstrating improved intravaginal ejaculatory latency time (IELT), according to a meta-analysis. Moreover, combining paroxetine with tadalafil or behavioural therapy was better than paroxetine alone in improving IELT.

Audrey Abella, 01 Feb 2019
Voiding behaviour is associated with bladder problems in women, an exploratory analysis shows.
Stephen Padilla, 31 Jan 2019
Oral dissolution therapy (ODT) effectively treats lucent renal stones regardless of stone size, a recent study has shown.
Audrey Abella, 30 Jan 2019
Reduced voided volume (VV, <150 mL) on initial uroflowmetry (UFM) may indicate severe storage symptoms in men with lower urinary tract symptoms (LUTS), a new study shows.
Special Reports
Dr. Joe Lee, 12 Apr 2018

A 70-year-old male with a history of diabetes, hyperlipidaemia and hypertension managed with atenolol presented to his family physician with lower urinary tract symptoms (LUTS). He was prescribed terazosin. Over the course of a year he noticed worsening erectile dysfunction (ED) with difficulty maintaining a hard erection until orgasm.

Dr. Devdatt Palnitkar, 16 Mar 2018
Dr Devdatt Palnitkar of the Palnitkar Hospital, Aurangabad, India, shared a practical guide to treating mild to moderate Overactive bladder (OAB).
02 Nov 2017
Nocturia is the most prevalent of the lower urinary tract symptoms (LUTS) and can cause a significant negative impact on an individual’s quality of life if left untreated.1,2 In a meeting held at University Malaya Medical Centre, Associate Professor Dr Ong Teng Aik shared his insights on the management of nocturia.
15 Jun 2017
At a recent morning tea symposium held in conjunction with the Malaysian Urological Conference 2016, Dr Marie Carmela Lapitan discussed about the benefits of combination therapy with alpha-blockers and 5-alpha-reductase inhibitors (5-ARIs) for the management of benign prostatic hyperplasia (BPH).
Roshini Claire Anthony, 25 Apr 2016

Elderly patients on androgen deprivation therapy (ADT) as part of prostate cancer treatment may be at an increased risk of depression, a recent study states.

Roshini Claire Anthony, 24 Mar 2016

Salvage radical prostatectomy (SRP) after radiation produces good long-term survival rates in men with prostate adenocarcinoma, according to a recent study.

Conference Reports
Jackey Suen, 30 Jan 2019

Recent research has revealed various potential biomarkers for metastatic castration-resistant prostate cancer (mCRPC), but several challenges remain in fully utilizing them in clinical practice.

Audrey Abella, 11 May 2018
Nanotechnology structured water was similarly effective as tadalafil in improving erectile function, suggesting that it could be a potential treatment option for erectile dysfunction (ED), according to a study presented at EAU held in Copenhagen, Denmark.
Audrey Abella, 30 Apr 2018
The selective β3-adrenoreceptor (AR) agonist vibegron showed superior efficacy over placebo for overactive bladder (OAB) treatment and was generally well-tolerated, according to a Japanese study presented at EAU 2018.

Roshini Claire Anthony, 23 Apr 2018

Targeted antibiotic prophylaxis – after a rectal swab to identify specific intestinal flora – does not appear to significantly impact the risk of urinary sepsis following a transrectal ultrasound (TRUS)-guided prostate biopsy, according to a recent study.

Roshini Claire Anthony, 20 Apr 2018

Conservative management appears to be the favoured option in managing non-penetrating renal trauma with urinary extravasation, according to a study presented at EAU 2018.

Christina Lau, 16 Apr 2018

MRI, with or without targeted biopsy, detects more clinically significant prostate cancer and less clinically insignificant prostate cancer than the standard transrectal ultrasonography (TRUS)-guided approach, enabling more than one-quarter of patients to safely avoid a biopsy altogether.

Christina Lau, 12 Apr 2018

Men with nonmetastatic castration-resistant prostate cancer (CRPC) have similar health-related quality of life (HRQoL) with apalutamide given on top of androgen deprivation therapy (ADT) vs ADT alone, according to new data from the SPARTAN (Prostate Androgen Receptor Targeting with ARN-509) trial presented at the European Association of Urology (EAU) 2018 Congress.